UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 313

Sortiert nach

Aggressive NK-Cell Leukemia

Frontiers in pediatrics, 2018-10, Vol.6, p.292-292

Ishida, Fumihiro

2018

Volltextzugriff (PDF)

T(o) be, or (not) to B, or both? Somatically mutated clonal T cells in common variable immunodeficiency and related immunodeficiencies

Haematologica (Roma), 2020-12, Vol.105 (12), p.2702

2020

Volltextzugriff (PDF)

Somatic mutations in acquired pure red cell aplasia

Seminars in hematology, 2022-07, Vol.59 (3), p.131-136

2022

Volltextzugriff (PDF)

Single-cell characterization of leukemic and non-leukemic immune repertoires in CD8 + T-cell large granular lymphocytic leukemia

Nature communications, 2022-04, Vol.13 (1), p.1981-1981, Article 1981

2022

Volltextzugriff (PDF)

Phase II Study of SMILE Chemotherapy for Newly Diagnosed Stage IV, Relapsed, or Refractory Extranodal Natural Killer (NK)/T-Cell Lymphoma, Nasal Type: The NK-Cell Tumor Study Group Study

Journal of clinical oncology, 2011-11, Vol.29 (33), p.4410-4416

2011

Volltextzugriff (PDF)

A novel germline GATA2 frameshift mutation with a premature stop codon in a family with congenital sensory hearing loss and myelodysplastic syndrome

International journal of hematology, 2021-08, Vol.114 (2), p.286-291

2021

Volltextzugriff (PDF)

Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target

Nature communications, 2018-04, Vol.9 (1), p.1567-12, Article 1567

2018

Volltextzugriff (PDF)

Clonal hematopoiesis in adult pure red cell aplasia

Scientific reports, 2021-01, Vol.11 (1), p.2253-2253, Article 2253

2021

Volltextzugriff (PDF)

Magnetic Resonance Imaging-negative, Rituximab-resistant Neurolymphomatosis as a Paradoxical Presentation of Relapsed Primary Adrenal Lymphoma

Internal Medicine, 2020/06/01, Vol.59(11), pp.1437-1443

2020

Volltextzugriff (PDF)

T cell clonal expansion and STAT3 mutations: a characteristic feature of acquired chronic T cell-mediated pure red cell aplasia

International journal of hematology, 2022-06, Vol.115 (6), p.816-825

2022

Volltextzugriff (PDF)

Identification of novel STAT5B mutations and characterization of TCRβ signatures in CD4+ T-cell large granular lymphocyte leukemia

Blood cancer journal (New York), 2022-02, Vol.12 (2), p.31-31, Article 31

2022

Volltextzugriff (PDF)

Aggressive natural killer cell leukemia: Therapeutic potential of l‐asparaginase and allogeneic hematopoietic stem cell transplantation

Cancer science, 2012-06, Vol.103 (6), p.1079-1083

2012

Volltextzugriff (PDF)

Allogeneic stem cell transplantation for patients with aggressive NK-cell leukemia

Bone marrow transplantation (Basingstoke), 2021-02, Vol.56 (2), p.347-356

2021

Volltextzugriff (PDF)

STAT3 mutations in natural killer cells are associated with cytopenia in patients with chronic lymphoproliferative disorder of natural killer cells

International journal of hematology, 2019-05, Vol.109 (5), p.563-571

2019

Volltextzugriff (PDF)

Successful Empiric Therapy for Postsplenectomy Sepsis with Campylobacter fetus in an Abattoir Worker with Follicular Lymphoma

Internal Medicine, 2018/11/15, Vol.57(22), pp.3329-3332

2018

Volltextzugriff (PDF)

Anti-COX-2 autoantibody is a novel biomarker of immune aplastic anemia

Leukemia, 2022-09, Vol.36 (9), p.2317-2327

2022

Volltextzugriff (PDF)

Severe Infection of Pseudomonas aeruginosa during Eculizumab Therapy for Paroxysmal Nocturnal Hemoglobinuria

Internal Medicine, 2018/01/01, Vol.57(1), pp.127-130

2018

Volltextzugriff (PDF)

STAT3 gene mutations and their association with pure red cell aplasia in large granular lymphocyte leukemia

Cancer science, 2014-03, Vol.105 (3), p.342-346

2014

Volltextzugriff (PDF)

CCR4-positive peripheral T-cell lymphoma presenting as eosinophilic pneumonia and developing from prolonged pustular psoriasis

Journal of international medical research, 2021-02, Vol.49 (2), p.300060521996165-300060521996165

2021

Volltextzugriff (PDF)

Phase II study of FLAGM (fludarabine + high-dose cytarabine + granulocyte colony-stimulating factor + mitoxantrone) for relapsed or refractory acute myeloid leukemia

International journal of hematology, 2019-04, Vol.109 (4), p.418-425

2019

Volltextzugriff (PDF)

Exogenous Magnesium Chloride Reduces the Activated Partial Thromboplastin Times of Lupus Anticoagulant-Positive Patients

PloS one, 2016-06, Vol.11 (6), p.e0157835-e0157835

2016

Volltextzugriff (PDF)

A screening method with lymphocyte percentage and proportion of granular lymphocytes in the peripheral blood for large granular lymphocyte (LGL) leukemia

International journal of hematology, 2017, Vol.105 (1), p.87-91

2017

Volltextzugriff (PDF)

Tumor long-axis diameter and SUVmax predict long-term responders in 90Y-ibritumomab tiuxetan monotherapy

International journal of hematology, 2019-01, Vol.109 (1), p.91-97

2019

Volltextzugriff (PDF)

1 – 25 von 313

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(254)
Mit Volltextzugriff
(269)

Publikationsform

Sprache

Englisch
(278)
Japanisch
(105)

Erscheinungsjahr

n.n

Thema

Science & Technology
(193)
Life Sciences & Biomedicine
(170)
Humans
(146)
Male
(99)
Female
(89)
Hematology
(69)
Middle Aged
(64)
Aged
(60)
Adult
(51)
Biological And Medical Sciences
(51)
Medical Sciences
(48)
Oncology
(47)
Animals
(36)
Mice
(31)
Hematologic And Hematopoietic Diseases
(26)
Aged, 80 And Over
(22)
Mutation
(22)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(19)
Biochemistry & Molecular Biology
(17)
Treatment Outcome
(17)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Aggressive NK-Cell Leukemia

T(o) be, or (not) to B, or both? Somatically mutated clonal T cells in common variable immunodeficiency and related immunodeficiencies

Somatic mutations in acquired pure red cell aplasia

Single-cell characterization of leukemic and non-leukemic immune repertoires in CD8 + T-cell large granular lymphocytic leukemia

Phase II Study of SMILE Chemotherapy for Newly Diagnosed Stage IV, Relapsed, or Refractory Extranodal Natural Killer (NK)/T-Cell Lymphoma, Nasal Type: The NK-Cell Tumor Study Group Study

A novel germline GATA2 frameshift mutation with a premature stop codon in a family with congenital sensory hearing loss and myelodysplastic syndrome

A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis

Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target

Clonal hematopoiesis in adult pure red cell aplasia

Magnetic Resonance Imaging-negative, Rituximab-resistant Neurolymphomatosis as a Paradoxical Presentation of Relapsed Primary Adrenal Lymphoma

T cell clonal expansion and STAT3 mutations: a characteristic feature of acquired chronic T cell-mediated pure red cell aplasia

Identification of novel STAT5B mutations and characterization of TCRβ signatures in CD4+ T-cell large granular lymphocyte leukemia

Aggressive natural killer cell leukemia: Therapeutic potential of l‐asparaginase and allogeneic hematopoietic stem cell transplantation

Allogeneic stem cell transplantation for patients with aggressive NK-cell leukemia

STAT3 mutations in natural killer cells are associated with cytopenia in patients with chronic lymphoproliferative disorder of natural killer cells

Successful Empiric Therapy for Postsplenectomy Sepsis with Campylobacter fetus in an Abattoir Worker with Follicular Lymphoma

Anti-COX-2 autoantibody is a novel biomarker of immune aplastic anemia

Severe Infection of Pseudomonas aeruginosa during Eculizumab Therapy for Paroxysmal Nocturnal Hemoglobinuria

STAT3 gene mutations and their association with pure red cell aplasia in large granular lymphocyte leukemia

CCR4-positive peripheral T-cell lymphoma presenting as eosinophilic pneumonia and developing from prolonged pustular psoriasis

Prognostic analysis according to the 2017 ELN risk stratification by genetics in adult acute myeloid leukemia patients treated in the Japan Adult Leukemia Study Group (JALSG) AML201 study

Phase II study of FLAGM (fludarabine + high-dose cytarabine + granulocyte colony-stimulating factor + mitoxantrone) for relapsed or refractory acute myeloid leukemia

Exogenous Magnesium Chloride Reduces the Activated Partial Thromboplastin Times of Lupus Anticoagulant-Positive Patients

A screening method with lymphocyte percentage and proportion of granular lymphocytes in the peripheral blood for large granular lymphocyte (LGL) leukemia

Tumor long-axis diameter and SUVmax predict long-term responders in 90Y-ibritumomab tiuxetan monotherapy

Suchergebnisse filtern